1
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Inter-Individual Variation in Levels of the Detoxifying Enzyme Glutathione S-Transferase pi (GSTP1) in Placentas from a Mexican Population

, , , , &
Pages 41-51 | Published online: 04 Dec 2011

REFERENCES

  • Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, and Morgan GJ. 2001. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 98(20):11592–11597.
  • Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, andWesterholm R. 2002. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 3:451–488.
  • Coles BF, Anderson KE, Doerge DR, Churchwell MI, Lang NP, and Kadlubar FF. 2000. Quantitative analysis of interindividual variation of glutathione S- transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res 60(3):573–579.
  • Coles BF and Kadlubar FF. 2003. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17(1.4):115.130.
  • Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, and Easton DF. 1999. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8(10):843.854.
  • Fenech M. 2001. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res 481:51.54.
  • Harries LW, Stubbins MJ, Forman D, Howard GC, andWolf CR. 1997. Identification of genetic polymorphisms at the glutathione S-transferase pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18(4):641.644.
  • Harris MJ, Coggan M, Langton L, Wilson SR, and Board PG. 1998. Polymorphism of the pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8(1):27.31.
  • Hayes JD and Strange RC. 2000. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61(3):154.166.
  • Hemmingsen A, Fryer AA, Hepple M, Strange RC, and Spiteri MA. 2001. Simultaneous identification of GSTP1 Ile 105 → Val105 and Ala114 → Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: Studies in patients with asthma. Respir Res 2(4):255.260.
  • Hengstler JG, Arand M, Herrero ME, and Oesch F. 1998. Polymorphisms of Nacetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Recent Results Cancer Res 154:47.85.
  • Hoensch H, Morgenstern I, Petereit G, Siepmann M, Peters WH, Roelofs HM, and Kirch W. 2002. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut 50(2):235.240.
  • Hu X, Herzog C, Zimniak P, and Singh SV. 1999. Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10 epoxide.induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. Cancer Res 59(10):2358.2362.
  • Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, and Ouchi Y. 1999. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 54(8):693.696.
  • Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, and Bell DA. 1999. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer, oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9(2):165.169.
  • Matthias C, Bockmuhl U, Jahnke V, Harries LW, Wolf CR, Jones PW, Alldersea J, Worrall SF, Hand P, Fryer AA, and Strange RC. 1998. The glutathione S-transferase GSTP1 polymorphism: Effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 8(1):1.6.
  • McRobie DJ, Glover DD, and Tracy TS. 1998. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab Dispos 26(4):367.371.
  • McRobie DJ, Glover DD, and Tracy TS. 1996. Regiospecificity of placental metabolism by cytochromes P450 and glutathione S-transferase. Gynecol Obstet Invest 42(3):154.158.
  • Obolenskaya M, Tschaikovskaya TL, Lebedeva LM, Macewicz LL, Didenko LV, and Decker K. 1997. Glutathione status of placentae from differently polluted regions of Ukraine. Eur J Obstet Gynecol Reprod Biol 71(1):23–30.
  • Pasanen M. 1999. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 38(1):81–97. Perera FP, Jedrychowski W, Rauh V, and Whyatt RM. 1999. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 3:451–460.
  • Pool-Zobel BL, Bub A, Liegibel UM, Treptow-van Lishaut S, and Rechkemmer G. 1998. Mechanisms by which vegetable consumption reduces genetic damage in humans. Cancer Epidemiol Biomarkers Prev 7(10):891–899.
  • Raijmakers MT, Bruggeman SW, Steegers EA, and Peters WH. 2002. Distribution of components of the glutathione detoxification system across the human placenta after uncomplicated vaginal deliveries. Placenta 23(6):490–496.
  • Ramsay HM, Harden PN, Reece S, Smith AG, Jones PW, Strange RC, and Fryer AA. 2001. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: A preliminary analysis. J Invest Dermatol 117(2):251–255.
  • Rowe JD, Nieves E, and Listowsky I. 1997. Subunit diversity and tissue distribution of human glutathione S-transferases: Interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325(Pt 2):481–486.
  • Sarmanova J, Benesova K, Gut I, Nedelcheva-Kristensen V, Tynkova L, and Soucek P. 2001. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin’s and non-Hodgkin’s lymphomas. Hum Mol Genet 10(12):1265–1273.
  • Steinkellner H, Rabot S, Freywald C, Nobis E, Scharf G, Chabicovsky M, Knasmuller S, and Kassie F. 2001. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 481:285–297.
  • Strange RC and Fryer AA. 1999. The glutathione S-transferases: Influence of polymorphism on cancer susceptibility. IARC Sci Publ 148:231–249.
  • Strange RC, Spiteri MA, Ramachandran S, and Fryer AA. 2001. Glutathione-S-transferase family of enzymes. Mutat Res 482:(1–2):21–26.
  • Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S, Koum-Besson E, Hemon D, Beaune P, and Loriot MA. 2002. Genetic polymorphisms of glutathione Stransferases as modulators of lung cancer susceptibility. Carcinogenesis 23(9):1475–1481.
  • Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, and Jernstrom B. 1998a. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19(3):433–436.
  • Sundberg K, Seidel A, Mannervik B, and Jernstrom B. 1998b. Detoxication of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione. FEBS Lett 438(3):206–210.
  • Terrier P, Townsend AJ, Coindre JM, Triche TJ, and Cowan KH. 1990. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 137(4):845–853.
  • Vassilev ZP, Robson MG, and Klotz JB. 2001. Outdoor exposure to airborne polycyclic organic matter and adverse reproductive outcomes: A pilot study. Am J Ind Med 40(3):255–262.
  • Watson MA, Stewart RK, Smith GB, Massey TE, and Bell DA. 1998. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19(2):275–280.
  • Whyatt RM, Bell DA, Jedrychowski W, Santella RM, Garte SJ, Cosma G, Manchester DK, Young TL, Cooper TB, Ottman R, and Perera FP. 1998. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19(8):1389–1392.
  • Whyatt RM, Perera FP, Jedrychowski W, Santella RM, Garte S, and Bell DA. 2000. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol Biomarkers Prev 9(2):207–212.
  • Zusterzeel PL, Nelen WL, Roelofs HM, Peters WH, Blom HJ, and Steegers EA. 2000a. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol Hum Reprod 6(5):474–478.
  • Zusterzeel PL, Peters WH, De Bruyn MA, KnapenMF, Merkus HM, and Steegers EA. 1999. Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies. Obstet Gynecol 94(6):1033–1038.
  • Zusterzeel PL, VisserW, Peters WH, MerkusHW, Nelen WL, and Steegers EA. 2000b. Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia. Obstet Gynecol 96(1):50–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.